insights_auto
Why is EDIT down 3,61%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
arrow_downward
-3,61%(-0,090) 1D
2,44 US$
arrow_upward
+1,53% (+0,037)bedtimeAfter hours
Closed: 23 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,44 US$
High
2,45 US$
Low
2,30 US$
Mkt. cap
368,59 მლნ.
Avg. vol.
2,92 მლნ.
Volume
1,31 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
lincolnjournal.com
·
57 წუთის წინ
CELH Deadline: Rosen Law Firm Urges Celsius Holdings, Inc. (NASDAQ: CELH) Stockholders to Contact the Firm for Information About Their Rights
FinancialContent
·
2 საათის წინ
About Us
AOL.com
·
1 საათის წინ
3 Dividend ETFs With Over $10 Billion Each Pay Up to 3.31% and Beat the S&P 500 Over the Past Year
Bloomberg.com
·
8 საათის წინ
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc